BEMOTRIZINOL REGULATION

US FDA regulates sunscreens as OTC drugs not as cosmetics. The manufacturers of sunscreen products must comply with drug standards such as active ingredient requirements, specific SPF and broad-spectrum testing methods and Drug facts labeling.

Apart from that, sunscreen manufacturers must comply with all drug registration requirements, including cGMP (Current Good Manufacturing Practice), Establishment registrationFDA Labeler code request, Drug listing and drug label compliance and they are entitled to pay OMUFA fee as well.

Active Ingredients

Sunscreens use either mineral or chemical UV filters. The FDA permits a specific set of active ingredients, with a notable update expanding the list:

  • Bemotrizinol: It is first new active ingredient added by FDA to OTC monograph under CARES Act after 2 decades since it is recognized as Generally Recognized as Safe and Effective (GRASE) for use in sunscreens by adults and children 6 months of age and older.
  • Zinc Oxide and Titanium Dioxide: These two mineral filters are the only ones currently classified as Generally Recognized as Safe and Effective (GRASE)
  • Chemical Filters: Twelve other chemical filters are currently undergoing review for GRASE status, requiring additional safety data.
  • Banned Ingredients: PABA and trolamine salicylate are deemed not safe and effective.

Dosage forms

FDA approved dosage forms of sunscreen are oils, lotions, creams, gels, butters, pastes, ointments, sticks are classified as GRASE.

For newly approved OTC monograph active ingredients like Bemotrizinol, FDA limits this to pump sprays or bag-on-valve systems to prevent propellant contact and minimize inhalation risks.

Wipes or Towelettes, body washes or cleansers and shampoos are not considered as GRASE so these forms cannot be sold without approved NDA.

Labeling and Claims Requirements

  • Water Resistance: Manufacturers cannot use terms like “waterproof,” “sweatproof,” or “sunblock”. Instead, labels must explicitly state if the product remains effective for 40 or 80 minutes while swimming or sweating.
  • Broad-Spectrum Protection: Sunscreens with SPF 15 or higher would be required to provide broad-spectrum protection, meaning they must protect against both UVA and UVB radiation.
  • Protection Limits: Sunscreens cannot claim to provide protection for longer than 2 hours without reapplication.
  • The FDA proposed clearer labeling requirements for sunscreen products to help consumers identify key product information such as effectiveness claim, Water resistance statements, statement of identity, indications of use, warnings, and direction of use.

All OTC drug products, including sunscreens, must have an expiration date unless stability testing shows they remain stable for at least three years.

Liberty Management Group provides assistance with drug establishment registration, drug listing and label review and US agent service to foreign drug companies.

Sudha S

Regulatory Consultant

Email : office@libertymanagement.us

www.fdahelp.us

ANTACIDS FDA REGULATION

Antacids are over the counter (OTC) drugs that helps with indigestion and heartburn by neutralizing stomach acids. Usually, antacids come in chewable tablets or liquid can be purchased from pharmacies without any prescription.

The active ingredients used in antacids vary depending on the type of brand. The most common ingredients are as below.

  • Alginate.
  • Aluminum hydroxide.
  • Calcium carbonate.
  • Magnesium carbonate.
  • Magnesium hydroxide.
  • Magnesium trisilicate.
  • Sodium bicarbonate.

To market Antacids in the US, below are process the company must comply with.

  • Drug establishment registration
  • Product listing
  • Label compliance
  • cGMP regulations

1. Drug Establishment Registration

Every domestic or foreign establishment that manufactures, repacks, or relabels drug products (including antacids) for the U.S. market must register with the FDA

  • Timing: New facilities must register within 5 days of beginning operations.
  • Renewal: Registration must be renewed annually between October 1 and December 31.
  • Verification: Registration can be verified at  https://www.accessdata.fda.gov/scripts/cder/drls/

2. Product Listing

  • Registered facilities are required to list all drug products they market. Each product is assigned to a unique National Drug Code (NDC)
  • Compliance: Most antacids marketed under OTC Monograph M001.11, which sets standard rules for safety.

3. Label compliance

  • Labels must include “Drug facts’ with indications, warnings, direction of use and contact information to report adverse events.

Liberty Management Group , as a leading FDA consultant will provide assistance  with drug establishment registration, drug listing and label review.

Sudha S

Regulatory Consultant

Email : office@libertymanagement.us

www.fdahelp.us

DRUG LABELING

Drug label is a printed information which is included with any OTC drugs, prescription drugs or any dietary supplements. Drugs labels are regulated by FDA and provide information to healthcare providers and patients on safe and effective use of the product. The information on the labels must be accurate and should not be misleading

All drugs or drug products in finished package form is considered as misbranded if it does not comply with FDA labeling requirements. The labels needs to have the name and place of business of the manufacturer, packer or distributor.

All registered drug establishments which includes API manufacturer, bulk manufacturer, contract manufacturer, repackers, relabelers are required to list their products under their own labeler code, however NDC number is not required to appear on all drug labels, including the label of any prescription drugs given to a customer.

Drugs labels should contain all drug facts which includes active ingredients, purpose and uses of the drug, directions, other information, inactive ingredients, phone numbers if there is any questions or comments.

When there is an expiration date on the drug products, it should appear on the container and also in outer package. However, if it is a single dose drug product packed in individual cartons, the expiry date should be on the individual carton not on the product container.

Manufacturers, Contract manufacturers, repackers, relabelers, and private label distributors of a human prescription drugs or an over-the-counter (OTC) drugs that is regulated under the FD&C act are not required to have bar code on the products. However, if the same drug product that are sold or used in the hospitals are required to put bar code on their products.

Liberty Management Group provides assistance with drug establishment registration, drug listing and label review.

Sudha S

Regulatory Consultant

Email : office@libertymanagement.us

www.fdahelp.us